Difficulty: Medium
Average Score: 85%
Testbank
The nurse admits a patient to an oncology unit that is a site for a study on the efficacy of a new chemotherapeutic drug. The patient knows that placebos are going to be used for some participants in the study but does not know that he is receiving a placebo. When is it ethically acceptable to use placebos?
Correct answer
D
Rationale
When the patient knows placebos are being used and is involved in the decision-making process.
Ethically, utilizing placebos is acceptable when participants are fully informed and consent to their use, fostering autonomy and trust. This transparency ensures patients understand the study's design and their role, thereby respecting their rights and enabling informed participation in the research process.
A: Whenever the potential benefits of a study are applicable to the larger population. This rationale overlooks the necessity for informed consent and patient autonomy, which are crucial in ethical research practices.
B: When the patient is unaware of it and it is deemed unlikely that it would cause harm. This reasoning disregards the ethical obligation to inform patients about their treatment, compromising their autonomy and trust in medical practices.
C: Whenever the placebo replaces an active drug. This approach fails to consider ethical standards that prioritize informed consent, potentially misleading participants regarding the nature of their treatment and its effects.
Ethically, utilizing placebos is acceptable when participants are fully informed and consent to their use, fostering autonomy and trust. This transparency ensures patients understand the study's design and their role, thereby respecting their rights and enabling informed participation in the research process.
A: Whenever the potential benefits of a study are applicable to the larger population. This rationale overlooks the necessity for informed consent and patient autonomy, which are crucial in ethical research practices.
B: When the patient is unaware of it and it is deemed unlikely that it would cause harm. This reasoning disregards the ethical obligation to inform patients about their treatment, compromising their autonomy and trust in medical practices.
C: Whenever the placebo replaces an active drug. This approach fails to consider ethical standards that prioritize informed consent, potentially misleading participants regarding the nature of their treatment and its effects.